Scope of the Study
Precision medicine software is a software used in the personalized treatment and detection of diseases, such as cancers, genetic disorders, cardiac & infectious diseases, and others. This software assists physicians in choosing a treatment method based on the patientís genetic makeup and lifestyle habits. The factors such as Increased Deployments of Precision Medicine Software and Increased Government Support in Precision Medicine Initiatives are driving the global precision medicine software market.
The market study is being classified, by Application (Oncology, Pharmacogenomics, Rare Diseases and Other Applications) and major geographies with country level break-up.
Syapse, Inc. (United States), 2bPrecise LLC (Israel), Foundation Medicine, Inc. (United States), Fabric Genomics (United States), SOPHiA GENETICS SA (Switzerland), PierianDx, Inc. (United States), N-of-One, Inc. (United States), Human Longevity, Inc. (United States), Translational Software, Inc. (United States), Sunquest Information Systems Inc. (United States) and Gene42, Inc. (Canada) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are LifeOmic Health, LLC (United States) and NantHealth, Inc. (United States).
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Precision Medicine Software market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Precision Medicine Software market by Type, Application and Region.
On the basis of geography, the market of Precision Medicine Software has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increased Deployments of Precision Medicine Software
- Increased Government Support in Precision Medicine Initiatives
- Partnerships Among Pharmaceutical and Software Companies
- Technological Advancements in the Healthcare Industry
- Increased Adoption of Cloud-Based Solutions
- Lack of Reimbursement For Precision Medicine-based Treatments
- High-Cost Associated with the Deployment of Software
- Growing Demand from End-users
- Increased Opportunities in Emerging Countries
- High Complexed Data Associated with Precision Medicine Software
In June 2018, Data-driven medicine company SOPHiA GENETICS has completed the acquisition of French tech company Interactive Biosoftware (IBS). IBS created Alamut, which is said to be the most used decision support software for clinical genomic data interpretation.
Key Target AudiencePrecision Medicine Software Developers, Emerging Companies, Research Professionals and End-users
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase